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IntroductIon
Classical DCs represent a discrete lineage distinguishable 
in ontogeny and function from macrophages (Merad et al., 
2013). Previously, we and others observed that Zbtb46 ex-
pression is a trait shared by all classical DCs and not shared by 
macrophages (Meredith et al., 2012; Satpathy et al., 2012a). 
However, no single transcriptomic or functional characteris-
tic is sufficient to distinguish the classical, plasmacytoid, and 
monocyte-derived subsets of DCs taken as a whole from 
macrophage subsets (Hume et al., 2013).
The biology of monocyte-derived DCs (moDCs) is 
of considerable interest because of their use in many human 
DC-based cancer immunotherapies (Anguille et al., 2014). 
It is clear that monocytes isolated from the mouse can 
differentiate into moDCs upon treatment with GM-CSF 
and IL-4 (Inaba et al., 1992; Sallusto and Lanzavecchia, 
1994) and acquire Zbtb46 expression under such condi-
tions (Satpathy et al., 2012a). Those mouse cells are a het-
erogeneous population comprising both macrophage-like 
and DC-like fractions (Helft et al., 2015), although it is 
unclear whether human moDCs in vitro are similarly 
heterogeneous. In the context of inflammation, cells that 
express the surface markers MHC class II (MHC-II), 
CD11c, and Ly-6C have been identified as in vivo moDCs 
(Langlet et al., 2012; Merad et al., 2013; Plantinga et al., 
2013). Further, depletion of Ly-6Chi monocytes using an 
anti-CCR2 antibody decreases the frequency of Ly-6Clo 
Zbtb46-GFP+ cells in the inflamed gut (Zigmond et al., 
2012). Thus, moDCs may lose expression of Ly-6C and 
acquire expression of Zbtb46 upon differentiation from 
monocytes (Zigmond et al., 2012); alternatively, Ly-6Chi 
monocytes may help to recruit Zbtb46-expressing DCs. 
Some have suggested that Ly-6C+ moDCs might be in-
distinguishable from monocyte-derived macrophages and 
myeloid-derived suppressor cells (Guilliams et al., 2014; 
Chow et al., 2016) or even from relatively undifferentiated 
monocytes (Jakubzick et al., 2013).
Langerhans cells (LCs) are branched, unpigmented, 
and slowly dividing cells resident in the epidermis with an 
unresolved relationship to other myeloid subsets (Satpathy 
et al., 2012b; Guilliams et al., 2014). They develop from em-
bryonic monocytes and are replenished under inflammatory 
conditions by progenitors in the blood or BM (Merad et al., 
2002; Ginhoux et al., 2006; Hoeffel et al., 2012; Seré et al., 
2012). Like microglia, LCs are unaffected by loss of either 
the cytokine Flt3L or its receptor Flt3 and instead require 
IL-34 signaling through M-CSFR (Ginhoux et al., 2006, 
2009; Kingston et al., 2009; Greter et al., 2012; Wang et al., 
2012). However, like classical DCs and unlike macrophages, 
activated LCs increase migration to draining LNs (Silber-
berg-Sinakin et al., 1976), where they up-regulate expres-
sion of genes such as Flt3 and Zbtb46 (Miller et al., 2012; 
current systems for conditional gene deletion within mouse macrophage lineages are limited by ectopic activity or low effi-
ciency. In this study, we generated a Mafb-driven cre strain to determine whether any dendritic cells (dcs) identified by 
Zbtb46-GFP expression originate from a Mafb-expressing population. Lineage tracing distinguished macrophages from classi-
cal dcs, neutrophils, and B cells in all organs examined. At steady state, Langerhans cells (Lcs) were lineage traced but also 
expressed Zbtb46-GFP, a phenotype not observed in any other population. After exposure to house dust mite antigen, 
Zbtb46-negative cd64+ inflammatory cells infiltrating the lung were substantially lineage traced, but Zbtb46-positive cd64− 
cells were not. these results provide new evidence for the unique identity of Lcs and challenge the notion that some inflam-
matory cells are a population of monocyte-derived dcs.
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Satpathy et al., 2012b). LCs that migrate out of human skin 
explants also express abundant ZBTB46 mRNA (Artyomov 
et al., 2015), and depletion of Zbtb46-expressing cells de-
creases the frequency of LCs among cells that migrate out of 
mouse skin explants and among cells within mouse draining 
LNs (Mollah et al., 2014). In other respects, LC migration 
at steady state is poorly understood (Kaplan, 2010), in part 
because the genetic models used in some studies cannot dis-
tinguish LCs from other lineages. For example, a langer-
in-driven fluorescent reporter developed to track LCs also 
labels classical DCs in the dermis (Kissenpfennig et al., 2005; 
Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al., 2007). 
Similarly, lineage tracing using LysM-Cre labels DCs in the 
dermis along with langerin-expressing cells in the draining 
LN (Jakubzick et al., 2008).
For those reasons, we sought to examine whether a 
macrophage reporter model could clarify the various ori-
gins of Zbtb46-expressing DCs observed in vivo. Currently 
available systems do not permit conditional gene deletion 
strictly within macrophage lineages (Abram et al., 2014). For 
example, LysM-Cre (Clausen et al., 1999) promotes signifi-
cant deletion in macrophages and neutrophils, and F4/80-Cre 
(Schaller et al., 2002) deletes incompletely among macro-
phage populations (Abram et al., 2014). CD11c-Cre (Caton 
et al., 2007) deletes robustly in alveolar macrophages and in 
classical and plasmacytoid DCs, whereas Cx3cr1-Cre deletes 
in many subsets of macrophages and classical DCs (Abram 
et al., 2014). Thus, we set out to design a new lineage- 
tracing model that would be more faithfully restricted to 
macrophages to study the overlap between macrophage pop-
ulations and Zbtb46-expressing DCs.
resuLts And dIscussIon
Generation of a Maf b-driven lineage-tracing model
Using principal component analysis to compare gene expres-
sion in macrophages and DCs, we proposed that a reporter 
based on expression of the gene that encodes transcription 
factor Maf B could distinguish macrophages from DCs (Sat-
pathy et al., 2012b). In myeloid progenitors, Maf B represses 
erythroid and DC fate (Kelly et al., 2000; Bakri et al., 2005). 
In resident macrophages, Maf B and its paralog c-Maf repress 
a network of self-renewal genes and are transiently down- 
regulated during cell proliferation (Soucie et al., 2016). Tumor- 
associated myeloid cells have been identified as macrophages 
rather than DCs partly on the basis of Maf b mRNA expres-
sion (Franklin et al., 2014).
We targeted C57BL6/N mouse embryonic stem cells 
to insert sequences encoding FLAG-tagged mCherry fluo-
rescent protein and Cre recombinase into the endogenous 
Maf b locus. We used sequences encoding self-cleaving 
2A peptides (Ryan et al., 1991; Szymczak-Workman et 
al., 2012) to separate those exogenous protein-coding se-
quences from each other and from the endogenous sin-
gle-exon Maf b coding sequence preserved upstream 
(Fig.  1). Our in-frame knock-in targeting strategy was 
informed by observations that protein synthesis rate and 
mRNA abundance together explain the vast majority 
of variation in protein abundance (Schwanhäusser et al., 
2011; Li et al., 2014; Jovanovic et al., 2015). In using 2A 
peptides that yield almost stoichiometric protein coex-
pression (Szymczak-Workman et al., 2012), our aim was 
to generate an allele that recapitulates the characteristics of 
wild-type Maf b in transcription and translation.
Our attention to faithful expression of Maf B from 
the mutated allele was prompted by evidence that Maf b- 
haploinsufficient mice exhibit subtle defects in hemato-
poiesis (Sultana et al., 2009) and by reports that aberrant 
expression of that protein can severely decrease viability 
of the organism. The kreisler (kr) mutation is a radiation- 
induced chromosomal inversion that separates an intact 
Maf b transcriptional unit from putative distal enhancer el-
ements (Cordes and Barsh, 1994). Mice homozygous for 
the kr mutation rarely survive to sexual maturity and show 
gross behavioral deficits caused by abnormalities in hind-
brain and inner ear development (Hertwig, 1942; Cordes 
and Barsh, 1994). In contrast, mice homozygous for our 
targeted allele (which we call Maf B-mCherry-Cre) sur-
vived into adulthood and were reproductively competent. 
They showed behavior indistinguishable from wild-type 
littermates, never manifesting the circling or dancing 
movement disorder observed in kr/kr mice (Hertwig, 
1942). These observations suggest that regulation of the 
Maf b locus was minimally altered by the in-frame inser-
tion of sequences encoding mCherry and Cre.
To generate lineage-tracing mice, we first crossed 
Zbtb46-GFP mice (Satpathy et al., 2012a) to R26-stop-YFP 
mice, which have a loxP-flanked stop sequence upstream 
of an enhanced YFP gene inserted into the constitutive and 
ubiquitous Gt(ROSA)26Sor locus (Srinivas et al., 2001); we 
then crossed either those progeny or R26-stop-YFP mice 
to Maf B-mCherry-Cre mice.
Figure 1. targeting strategy to generate MafB-mcherry-cre 
knock-in mice. Arrows indicate orientation of coding sequences, and 
green bars indicate UTRs. AmpR, ampicillin resistance; DT-A, diphtheria 
toxin fragment A; HA, homology arm; NeoR, neomycin resistance.
o
n
 D
ecem
ber 21, 2016
D
ow
nloaded from
 
Published October 17, 2016
2555JEM Vol. 213, No. 12
Maf b-driven lineage tracing distinguishes monocytes  
and macrophages from other hematopoietic lineages
In the spleen of lineage-tracing mice, Maf b-mCherry was 
expressed abundantly in F4/80+ macrophages, and expres-
sion of the lineage-tracing marker YFP was found in nearly 
all F4/80+ macrophages but at background frequency among 
the classical DC subsets (Fig. 2 A and Fig. S1 A). In the brain, 
Maf b-mCherry was detectable in microglia, and YFP expres-
sion was found in nearly all such cells (Fig. 2 B and Fig. S1 
B). In the blood, Maf b-mCherry expression was detectable 
only faintly (not depicted); however, YFP expression was ob-
served in ∼10% of Ly-6Chi monocytes and ∼40% of Ly-6Clo 
monocytes (Fig. 2 C and Fig. S1 C). In contrast, we observed 
expression of the lineage-tracing marker YFP at a background 
frequency ranging from ∼1% to ∼6% in CD45− cells, B cells, 
and neutrophils (Fig. 2 C and Fig. S1 C), which may reflect 
some quantity of Maf b expression in the hematopoietic stem 
cell compartment (Sarrazin et al., 2009).
We detected no interpretable differences in gene expres-
sion between YFP+ and YFP− Ly-6Clo monocytes by microar-
ray analysis (Fig. 2 D), suggesting that together they represent a 
single incompletely lineage-traced subset. We surmise that the 
short half-life (∼20 h at steady state) of Ly-6Chi monocytes 
(Ginhoux and Jung, 2014) accounts for the lack of extensive 
lineage-tracing activity. Although gene expression microarray 
data show some up-regulation of the Maf b transcript at the 
Ly-6Chi monocyte stage (Gautier et al., 2012), the lineage-trac-
ing marker YFP would be detectable at the same stage only if 
transcription and translation of Cre, Cre-mediated recombi-
nation, and transcription, translation, and maturation of YFP 
Figure 2. Monocyte progeny are marked by 
Mafb-driven lineage tracing. (A) Macrophages 
(MΦ) in MafB-mCherry-Cre × R26-stop-YFP × 
Zbtb46-GFP mouse spleen, gated as in Fig. S1 A, 
are displayed for expression of Mafb-mCherry and 
lineage-tracing marker YFP in a two-color histo-
gram, and classical DC subsets are compared for 
expression of YFP. Shown is one sample and a box 
plot representing first quartile, median, and third 
quartile frequencies (n ≥ 5 animals over at least 
three independent experiments). (B) Microglia in 
MafB-mCherry-Cre × R26-stop-YFP mouse brain, 
gated as in Fig. S1 B, are displayed for expression of 
Mafb-mCherry and YFP in a two-color histogram. 
Shown is one representative sample (n ≥ 3 animals 
over at least two independent experiments). (A and 
B) Numbers indicate percentage of cells within the 
indicated gate, and dotted gray lines show fluores-
cent signal measured in non-mCherry and non-YFP 
control samples. (C) Lineages in MafB-mCherry-Cre 
× R26-stop-YFP × Zbtb46-GFP mouse blood, gated 
as in Fig. S1 C, are compared for expression of YFP. 
Shown is a box plot representing first quartile, me-
dian, and third quartile frequencies (n ≥ 8 animals 
over at least four independent experiments). mo., 
monocytes. (D) Heat map showing relative gene 
expression in the indicated monocyte subsets for 
gene expression microarray probe sets differentially 
expressed in Ly-6Chi and Ly-6Clo monocytes. Shown 
are averages of two biological replicates, excluding 
one YFP− Ly-6Clo monocyte sample below qual-
ity control thresholds. (E) Monocytes identified in 
C, distinguished on the basis of Ly-6C expression 
(left), are compared for expression of YFP (right). 
Shown is one representative sample. (F) Maturing 
macrophages in MafB-mCherry-Cre × R26-stop-
YFP × Zbtb46-GFP mouse small intestinal lamina 
propria, identified by surface markers as indicated 
(left) after pregating as in Fig. S1 D, are compared 
for expression of YFP (right). Shown is one repre-
sentative sample (n = 4 animals over two inde-
pendent experiments). (E and F) Numbers indicate 
percentage of cells within the indicated gate.
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occur significantly within a day’s span. By comparison, Ccr2-
CreERT2–based lineage tracing marks nearly all Ly-6Chi mono-
cytes, but Ccr2 expression is up-regulated before commitment 
to the monocyte–macrophage lineage at the macrophage–DC 
progenitor stage, and lineage tracing is detectable in the com-
mon DC progenitor and its progeny (Croxford et al., 2015).
In the blood, Ly-6Clo YFP+ monocytes showed greater 
intensities of YFP expression than did developing Ly-6Cint 
YFP+ monocytes; however, the perceived effect was subtle 
because the latter population was few in number (Fig. 2 E). 
In the gut lamina propria, Ly-6Chi monocytes differentiate 
into CD64hi Ly-6Clo MHC-II+ macrophages through inter-
mediary stages in a monocyte waterfall (Tamoutounour et 
al., 2012; Bain et al., 2014). We found that those intermediary 
stages also showed an intermediate frequency and interme-
diate intensities of YFP expression (Fig. 2 F and Fig. S1 D). 
Because YFP expression is under the control of a constitutive 
and ubiquitous promoter, these data suggest that cells adopt-
ing macrophage identity accumulated increasing concentra-
tions of YFP until a steady-state concentration was reached 
late during differentiation.
Spleen and small intestinal macrophages express Maf b 
mRNA more abundantly than do macrophages in nearly any 
other organ (Gautier et al., 2012). To broaden our analysis, 
we used surface markers to identify BM and alveolar macro-
phages, which express little or no Maf b mRNA (Gautier et 
al., 2012). In some tissues, however, characteristic macrophage 
surface markers such as F4/80 cannot unambiguously dis-
tinguish those cells from other populations (Randolph and 
Merad, 2013). In the BM, we found that cells with the high-
est abundance of F4/80 showed substantial lineage tracing 
(Fig. 3 A and Fig. S1 E). In the lung, F4/80+ cells varied in 
Ly-6C expression; alveolar macrophages identified within the 
Ly-6Clo fraction showed no detectable Maf b-mCherry ex-
pression but substantial lineage tracing, whereas a population 
of cells within the Ly-6Cint fraction expressing similar surface 
markers showed no detectable Maf b-mCherry expression 
and no lineage tracing (Fig. 3 B, Fig. S1 F, and not depicted). 
Thus, Maf B-mCherry-Cre–based lineage tracing can identify 
macrophages even where those cells express little or no Maf b 
mRNA. Furthermore, this system can help to distinguish 
such populations from other cells that are similar in expres-
sion of surface markers such as F4/80.
Small peritoneal macrophages (SPMs) have been 
found to exhibit some characteristics of DCs, including 
dendritic morphology and expression of markers such as 
CD209 (DC-SIGN; Cain et al., 2013; Cassado et al., 2015). 
Although SPMs and DCs have been distinguished on the 
basis of M-CSFR or CD11c expression (Gautier et al., 
2012; Cain et al., 2013), both populations are marked in 
lineage-tracing systems based on Cx3cr1-Cre or LysM-Cre 
(Cain et al., 2013). Using Maf B-mCherry-Cre–based lin-
eage tracing in conjunction with the Zbtb46-GFP reporter 
allele, we found a population of M-CSFR+ classical DCs 
that lacked expression of YFP (Fig.  3  C and Fig. S1 G). 
Figure 3. Mafb-driven lineage tracing segregates macrophages from 
other populations. (A) Macrophages in MafB-mCherry-Cre × R26-stop-
YFP × Zbtb46-GFP mouse BM, identified by surface markers as indicated 
(orange) after pregating as in Fig. S1 E, are compared with F4/80+ cells of 
similar immunophenotype (green) for expression of lineage-tracing marker 
YFP. Shown is one representative sample (n ≥ 4 animals over at least two 
independent experiments). (B) Alveolar macrophages in MafB-mCherry-Cre 
× R26-stop-YFP × Zbtb46-GFP mouse lung, identified by surface markers 
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After excluding those cells, large peritoneal macrophages 
(LPMs) and most SPMs expressed YFP (Fig.  3  C), and 
SPMs and DCs exhibited distinct morphologies (Fig. 3 D). 
In concordance with gene expression microarray data 
(Gautier et al., 2012), LPMs expressed greater quantities of 
Maf b-mCherry than did SPMs, and LPMs isolated from 
mice homozygous for the Maf B-mCherry-Cre allele ex-
pressed Maf b mRNA as abundantly as did LPMs isolated 
from wild-type mice (not depicted).
In the skin-draining LN, cells that express DC-SIGN 
accumulate within the MHC-IIhi compartment after intrave-
nous LPS injection (Cheong et al., 2010). Those cells express 
Zbtb46-GFP and fail to accumulate in Flt3L-deficient mice 
after treatment with LPS (Meredith et al., 2012; Satpathy 
et al., 2012a), which suggests that they are a population of 
classical DCs not derived from monocytes as was initially 
proposed. After LPS treatment of Maf B-mCherry-Cre–based 
lineage–tracing mice carrying the Zbtb46-GFP allele, we 
confirmed that MHC-IIhi CD11c+ Sirp-α+ DC-SIGN+ cells 
in the inguinal LN were uniformly positive for expression of 
Zbtb46-GFP, but we did not observe expression of YFP in 
that population above a background frequency (Fig. 3 E and 
Fig. S1 H). These data suggest that such cells are not derived 
from a Maf b-expressing population.
Lcs are Zbtb46-expressing cells marked  
by Maf b-driven lineage tracing
In the epidermis, expression of the surface marker epithelial 
cell adhesion molecule (EpCAM) is sufficient to distinguish 
LCs from classical DCs (Henri et al., 2010). However, in the 
skin-draining LN, radioresistant LCs are greatly outnumbered 
by donor-derived cells within the EpCAM+ compartment 
after reconstitution of irradiated mice using heterologous 
BM (Henri et al., 2010). Therefore, we assessed whether dual 
macrophage and DC characteristics observed in LCs could be 
explained by population heterogeneity at steady state.
Using Maf B-mCherry-Cre–based lineage tracing, we 
first examined LCs in the inguinal LN. In that tissue, all 
EpCAM+ MHC-II+ cells were uniformly positive for ex-
pression of both Zbtb46-GFP and YFP, whereas EpCAM− 
Zbtb46-GFP+ DC populations did not show YFP expression 
above background frequency (Fig.  4  A). Conversely, we 
found that almost all Zbtb46-GFP+ YFP+ cells were positive 
for expression of EpCAM and MHC-II, whereas cells that 
did not express both Zbtb46-GFP and YFP also did not ex-
press EpCAM (not depicted). These observations suggest that 
Maf b-expressing cells are the sole source of EpCAM+ cells in 
the skin-draining LN at steady state.
We next examined LCs in the epidermis (Fig. 4, B and 
C; Fig. S2, A and B). In that tissue, nearly all CD45+ MHC-II+ 
EpCAM+ CD24+ cells expressed abundant Zbtb46- 
GFP and YFP, although Maf b-mCherry expression did not 
reach the limit of detection (Fig.  4  B and not depicted). 
The presence of Zbtb46-GFP in skin LCs was unexpected 
because a previous study  has found that the Zbtb46 tran-
script is expressed at a similar abundance in skin LCs and 
splenic plasmacytoid DCs, much less than that in classi-
cal DCs (Miller et al., 2012; Satpathy et al., 2012b), and 
plasmacytoid DCs do not express detectable Zbtb46-GFP 
(Satpathy et al., 2012a). We also used anti-Zbtb46 anti-
body to compare protein expression in Zbtb46-sufficient 
(Zbtb46+/+) and Zbtb46-deficient (Zbtb46gfp/gfp) epidermal 
LCs (Fig. 4 C). Consistent with our earlier observation, we 
found that epidermal LCs expressed Zbtb46 protein. Thus, 
LCs are monocyte-derived cells that express Zbtb46 even at 
the tissue-resident stage.
Ly-6c+ monocyte-derived cells that infiltrate  
the lung are maturing macrophages
In the lung, administration of house dust mite (HDM) antigen 
induces an influx of cells that are distinguished from classical 
DCs by expression of CD64, Ly-6C, and MAR-1 (Plantinga 
et al., 2013). There has been disagreement as to whether these 
cells should be considered moDCs (Plantinga et al., 2013) 
or simply macrophages (Schlitzer et al., 2013). Thus, we used 
Maf B-mCherry-Cre–based lineage tracing to study the infil-
trating population after exposure to HDM antigen (Fig. 5 and 
Fig. S2 C). In the lung and mediastinal LN of HDM antigen–
treated mice, we found that CD45+ MHC-II+ CD11c+ CD11b+ 
CD64+ cells did not express Zbtb46-GFP (Fig. 5, B, D, and E). 
Instead, we observed a continuum of Ly-6C expression within 
that population in the lung, with the Ly-6Chi fraction express-
ing a lower abundance of YFP than did the Ly-6Clo fraction 
(Fig. 5 B). Because YFP expression is controlled by a constitutive 
and ubiquitous promoter, these results favor the interpretation 
that infiltrating CD45+ MHC-II+ CD11c+ CD11b+ CD64+ 
cells are progressively adopting a macrophage identity.
as indicated (red) after pregating as in Fig. S1 F, are compared with F4/80+ 
Siglec-F+ CD64+ cells of similar immunophenotype (blue) for expression 
of YFP. Shown is one representative sample (n ≥ 4 animals over at least 
two independent experiments). (C) MafB-mCherry-Cre × R26-stop-YFP × 
Zbtb46-GFP LPMs (purple) and SPMs (magenta), identified by surface 
markers as indicated after pregating as in Fig. S1 G, are compared for 
expression of Zbtb46-GFP and YFP in two-color histograms. Shown is 
one representative sample (n ≥ 3 animals over at least two independent 
experiments). (A–C) Numbers indicate percentage of cells within the in-
dicated gate, and dotted gray lines show fluorescent signal measured in 
non-mCherry and non-YFP control samples. (D) Macrophages (identified as 
Zbtb46-GFP− Ly-6G− CD11b+ Mafb-mCherry+ YFP+, which were uniformly 
M-CSFR+), distinguished as LPM (F4/80hi) or SPM (F4/80lo), and DCs (iden-
tified as Zbtb46-GFP+ CD11c+) were sorted from the peritoneum of MafB-
mCherry-Cre × R26-stop-YFP × Zbtb46-GFP mice and concentrated by 
Cytospin for morphological assessment by Wright–Giemsa staining. Shown 
are two representative cells for each population (n = 3 animals over two in-
dependent experiments). Bar, 20 µm. (E) DC-SIGN+ cells in the inguinal LNs 
of mice treated intravenously with vehicle (saline) or 10 µg LPS, identified 
by surface markers as indicated after pregating as in Fig. S1 H, are com-
pared for expression of Zbtb46-GFP and YFP. Shown is one representative 
sample for each group (n ≥ 2 animals per group over two independent ex-
periments). Numbers indicate percentage of cells within the indicated gate.
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Collectively, our results demonstrate that the 
Maf B-mCherry-Cre model is suitable for driving gene de-
letion specifically in macrophages, sparing deletion in DCs 
or neutrophils. Maf B is also expressed outside the hemato-
poietic system, where our model may find additional ap-
plications. In the mouse endocrine pancreas, for example, 
Maf B is expressed in mature α-cells but is also required 
for β-cell maturation (Artner et al., 2007). In the kidney, 
Maf B is required for podocyte foot process formation 
(Moriguchi et al., 2006).
By using a lineage-tracing system based on 
Maf B-mCherry-Cre, we found evidence that embryonic 
monocytes acquire Zbtb46 upon differentiation into LCs. In 
contrast, we found no evidence of similar cells in other organs 
at steady state (Fig.  6) or in the lung under inflammatory 
conditions. Instead, cells elicited by HDM antigen could be 
resolved into either Zbtb46-expressing DCs or CD64+ mac-
rophages. Although we cannot exclude the possibility that 
Maf b-expressing lineages can give rise to Zbtb46-expressing 
progeny under conditions not examined here, it appears that 
LCs may be unique in acquiring these distinctive characteris-
tics of macrophages and DCs.
MAterIALs And Methods
Mice
Maf B-mCherry-Cre mice were maintained on the 
C57BL/6N background by interbreeding or by breeding 
to C57BL/6NJ mice (stock no. 005304; The Jackson Lab-
oratory). To remove the neomycin resistance cassette, mice 
were bred to flippase (FLP) knock-in (B6N.129S4-Gt(RO-
SA)26Sortm1(FLP1)Dym/J) mice (stock no. 016226; The Jackson 
Laboratory) and then interbred to remove the FLP-express-
ing allele. The resulting strain is available at The Jackson Lab-
oratory (stock no. 029664).
Zbtb46-GFP (B6.129S6(C)-Zbtb46tm1.1Kmm) mice 
were generated by breeding 129S-Zbtb46tm1Kmm mice (Sat-
pathy et al., 2012a) to B6.C-Tg(CMV-cre)1Cgn/J mice 
(stock no. 006054; The Jackson Laboratory) to remove 
the neomycin resistance cassette. Offspring were bred to 
C57BL/6J mice for at least nine generations (removing the 
Cre-expressing transgene) and deposited at The Jackson 
Laboratory (stock no. 027618). R26-stop-YFP (B6.129X1- 
Gt(ROSA)26Sortm1(EYFP)Cos/J) mice were purchased from 
The Jackson Laboratory (stock no. 006148) and crossed to 
Zbtb46-GFP mice on the C57BL/6 background.
Experiments were performed using age-matched mice 
between 4 and 22 wk of age. Comparisons of treated mice 
with untreated mice used littermates for both groups; com-
parisons of fluorescent samples with nonfluorescent samples 
used, for the latter group, cells isolated from mice lacking the 
fluorescent markers of interest that were bred and maintained 
on the C57BL/6 background in the same facility. All mice 
were bred and maintained in a specific pathogen–free animal 
facility according to institutional guidelines and under proto-
cols approved by the Animal Studies Committee of Washing-
ton University in St. Louis.
Figure 4. Lcs at steady state are marked 
by Mafb-driven lineage tracing but ex-
press Zbtb46. (A) Migrated LCs in the inguinal 
LN of MafB-mCherry-Cre × R26-stop-YFP × 
Zbtb46-GFP mice are displayed for expression 
of Zbtb46-GFP and lineage-tracing marker 
YFP in a two-color histogram (top), and der-
mal DC populations in the same tissue iden-
tified by Zbtb46-GFP and CD24 are displayed 
for expression of YFP (bottom). Shown is one 
representative sample (n ≥ 4 animals over at 
least two independent experiments). (B) LCs in 
the epidermis of wild-type or MafB-mCherry-
Cre × R26-stop-YFP × Zbtb46-GFP (mCherry × 
YFP × GFP) mice, gated as in Fig. S2 A, are 
compared for expression of Zbtb46-GFP and 
YFP in two-color histograms. Shown is one 
representative sample per group (n ≥ 2 ani-
mals per group over at least two independent 
experiments). (A and B) Numbers indicate 
percentage of cells within the indicated gate. 
(C) LCs in the epidermis of wild-type (Zbtb46+/+) 
or Zbtb46-deficient (Zbtb46gfp/gfp) mice, gated 
as in Fig. S2 B, are compared for expression of 
Zbtb46-GFP and Zbtb46 protein in one-color 
histograms. Shown is one representative sam-
ple per group (n = 3 animals per group over 
two independent experiments).
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Generation of the Maf B-mcherry-cre targeted mutation
P2A-FLAG-mCherry, T2A-Cre, and mouse Maf B coding 
sequences were ligated serially into the pMSCV T2A-GFP 
retroviral overexpression vector, which was modified from 
the pMSCV IRES-GFP retroviral overexpression vector 
(Ranganath et al., 1998), to yield the pMSCV Maf B-P2A-
FLAG-mCherry-T2A-Cre retroviral overexpression vec-
tor. Primers used to amplify coding sequences by PCR 
are listed in Table S1.
The Maf b 3′–untranslated region (UTR) sequence was 
amplified from 129S6 genomic DNA using the following 
primers: 5′-ATT AGA ATT CTT TCT GTG AGT CCT GGC 
GG-3′ and 5′-ATT AAT CGA TGG GGA CTG CTT TTT TGT 
ACA AAC TTG TTG CCA GAG AAT GTC CCA AAC-3′. Both 
the amplified 3′-UTR fragment and pMSCV Maf B-P2A-
FLAG-mCherry-T2A-Cre retroviral overexpression vector 
were digested using EcoRI and ClaI and then ligated together. 
A Maf B-P2A-FLAG-mCherry-T2A-Cre-UTR fragment was 
Figure 5. Ly-6c+ monocyte-derived cells 
in the inflamed lung mature without ex-
pressing Zbtb46. (A) Experimental outline 
for intratracheal (i.t.) sensitization and chal-
lenge of MafB-mCherry-Cre × R26-stop-
YFP × Zbtb46-GFP mice using HDM antigen. 
(B) Classical DCs and monocyte-derived cells in 
the lung, identified by surface markers as indi-
cated after pregating as in Fig. S2 C, are com-
pared for expression of Ly-6C, lineage-tracing 
marker YFP, and Zbtb46-GFP after treatment 
with vehicle (saline) or HDM antigen following 
the schedule outlined in A. Shown is one repre-
sentative sample (n ≥ 4 HDM-treated animals 
over at least two independent experiments). 
Numbers indicate percentage of cells within 
the indicated gate. (C) Experimental outline 
for high-dose intratracheal sensitization and 
challenge of MafB-mCherry-Cre × R26-stop-
YFP × Zbtb46-GFP mice using HDM antigen. 
(D and E) Classical DCs and monocyte-derived 
cells in the lung (D) or mediastinal LN (E), 
identified by surface markers as indicated, are 
compared for expression of YFP and Zbtb46-
GFP after treatment with vehicle (saline) or 
HDM antigen following the schedule outlined 
in C. Shown is one representative sample (n = 
2 HDM-treated animals over two independent 
experiments). Numbers indicate percentage of 
cells within the indicated gate.
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released from the resulting vector by restriction digest using 
SacII, MluI, and Antarctic phosphatase (New England Biolabs, 
Inc.), and an ∼3-kb fragment containing Maf b 5′-UTR and 
upstream sequences was amplified from 129S6 genomic DNA 
and digested using MluI. The primers used to amplify the latter 
fragment were: 5′-ATT AAG ATC TGG GGA CAA CTT TGT 
ATA GAA AAG TTG CGG AGT GTG GTG TTC TCT CT-3′ 
and 5′-CGT CTT CTC GTT CTC CAG GT-3′. The digested 
fragments were inserted into the pDONR (P4-P1R) plas-
mid (Invitrogen) by a modified BP recombination reaction in 
which incubation at room temperature was followed by addi-
tion of a supplemental buffer (10 mM MgCl2 and 1 mM ATP) 
and T4 DNA ligase (New England Biolabs, Inc.) and incuba-
tion at 16°C for 5.5 h before addition of proteinase K solution 
to terminate the reaction. That reaction generated pENTR 
Maf B-P2A-FLAG-mCherry-T2A-Cre-UTR.
A loxP-flanked fragment containing a neomycin 
resistance gene under the control of the Pgk1 promoter 
(Pgk1-NeoR) was released by restriction digest from 
the pLNTK-targeting vector (Gorman et al., 1996) and 
ligated into the pENTR lox-Puro vector (Iiizumi et 
al., 2006) to yield pENTR lox-rNeo, as previously de-
scribed (Satpathy et al., 2012a). FLP recognition target 
(FRT) sites were introduced flanking the Pgk1-NeoR 
cassette by site-directed mutagenesis using Pfu DNA 
polymerase (Agilent Technologies) to yield pENTR lox-
FRT-rNeo. Flanking loxP sites were removed in a two-
step process. First, the loxP/FRT-flanked Pgk1-NeoR 
cassette was replaced with a synthetic DNA fragment 
purchased from Integrated DNA Technologies to yield 
an intermediate pENTR plasmid. Second, the inter-
mediate pENTR plasmid was digested using MfeI-HF 
(New England Biolabs, Inc.) and BamHI, and then was 
ligated to a Pgk1-NeoR fragment released from pENTR 
lox-FRT-rNeo using EcoRI and BamHI. Orientation 
of the synthetic fragment in the intermediate pENTR 
plasmid determined orientation of the Pgk1-NeoR 
fragment in the final product, yielding either pENTR 
FRT-Neo or pENTR FRT-rNeo. The sequence of the 
synthetic fragment was: 5′-TAC TAC GCG GCC GCG 
AAT TCG AAG TTC CTA TTC CGA AGT TCC TAT TCT 
CTA GAA AGT ATA GGA ACT TCA TTA AGG GTT CCG 
GAT CTA TAG ATC ATG AGT GGG AGG AAT GAG CTG 
GCC CTT AAT TTG GTT TTG CTT GTT TAA ATT ATG 
ATA TCC AAC TAT GAA ACA TTA TCA TAA AGC AAT 
AGT AAA GAG CCT TCA GTA AAG AGC AGG CAT TTA 
TCT AAT CCC ACC CCA CCC CCA CCC CCG TAG 
CTC CAA TCC TTC CAT TCA AAA TGT AGG TAC TCT 
GTT CTC ACC CTT CTT AAC AAA GTA TGA CAG GAA 
AAA CTT CCA TTT TAG TGG ACA TCT TTA TTG TTT 
AAT AGA TCA TCA ATT TCT GCA GAC TTA CAG CGG 
ATC CTT AAT TCA ATT GGA AGT TCC TAT TCC GAA 
GTT CCT ATT CTC TAG AAA GTA TAG GAA CTT CGA 
ATT CGA AGC GGC CGC CAT CAT-3′.
Homology arms were amplified by PCR from C57BL/6 
genomic DNA and the vector backbone was amplified from 
pDEST DTA-MLS (Iiizumi et al., 2006) using Q5 High-Fi-
delity DNA polymerase (New England Biolabs, Inc.) and 
primers listed in Table S2. A synthetic DNA fragment was 
purchased from Integrated DNA Technologies incorporat-
ing partial mCherry coding sequence, partial Maf b 3′-UTR 
sequence, and restriction sites for subsequent use. The se-
quence of the synthetic fragment was: 5′-GAG AGA GAC 
GCC TAC AAG GTC AAG TGC GAG AAA CTC GCC AAC 
TCC GGC TTC AGG GAG GCG GGC TCC ACC AGC GAC 
AGC CCC TCC TCT CCT GAG TTC TTT CTG GTC GAG 
GGC AGC GGC GCC ACG AAC TTC AGC CTG CTG AAG 
CAA GCA GGA GAT GTT GAA GAA AAC CCC GGC CCT 
GAT TAC AAG GAT GAC GAT GAC AAG GTG AGC AAG 
GGC GAG GAG GAT AAC ATG GCC ATC ATC AAG GAG 
TTC ATG CGC TTC AAG GTG CAC ATG GAG GGC TCC 
GTG AAC GGC CAC GAG TTC GAG ATC GAG GGC GAG 
GGC GAG GGC CGC CCC TAC GAG GGC ACC CAG ACC 
GCC AAG CTG AAG GTG ACC AAG GGT GGC CCC CTG 
CCC TTC GCC TGG GAC ATC CTG TCC CCT CAG TTC 
ATG TAC GGC TCC AAG GCC TAC GTG AAG CAC CCC 
GCC GAC ATC CCC GAC TAC TTG AAG CTG TCC TTC 
CCC GAG GGA TTT AAA TGG GAG CGC GTG ATG AAC 
TTC GAG GAC GGC GGC GTG GTG ACC GTG ACC CAG 
GAC TCC TCC CTG CAG GAC GGC GAG TTC ATC TAC 
AAG GTG AAG CTG CGC GGC ACC AAC TGA TGT GGC 
TCT TCG CCC CCC TCG TCC TTC CCA CTT CAG TTT 
Figure 6. A Zbtb46+ population marked by 
Mafb-driven lineage tracing is found in the 
skin but not in the spleen, lung, or small 
intestinal lamina propria at steady state. 
B220− cells from spleen samples in Fig.  2  A, 
CD45+ cells from lung samples in Fig.  3  B, 
CD45+ cells from small intestinal lamina pro-
pria samples in Fig. 2 F, and CD45+ cells from 
epidermis samples in Fig. 4 B are compared for 
expression of Zbtb46-GFP and lineage-tracing 
marker YFP in two-color histograms. Shown 
is one representative sample per tissue, each 
down-sampled to ∼5 × 104 cells.
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TAA GTT TTG TTG AGG GAA AGC GGC CGC TAA GGG 
AGA GAC AGA TGC CGA GAT CCA CAT CGT GCA GGA 
GTG TGT CCT TTA TTA TTG TTG GGT CTT GGG GCC 
AAA TTG ACA TAC ACA CAC CCA CGA CTG CTC CT-3′.
The amplified homology arm fragments, amplified 
vector backbone fragment, and synthetic fragment were as-
sembled using Gibson Assembly Master Mix (New England 
Biolabs, Inc.) to yield the first intermediate targeting plasmid.
The first intermediate targeting plasmid was linearized 
using NotI and Antarctic phosphatase (New England Bio-
labs, Inc.) and then was used for ligation to an FRT-flanked 
Pgk1-NeoR fragment  released from pENTR FRT-Neo or 
pENTR FRT-rNeo using NotI and BsrGI (having ensured 
that the pENTR vector backbone would not interfere with 
ligation by digesting with NheI and AflII after digesting with 
NotI and BsrGI). The ligation yielded the second interme-
diate targeting plasmid.
An ∼1-kb fragment containing a portion of the 3′-
UTR sequence was amplified from pENTR Maf B-P2A-
FLAG-mCherry-T2A-Cre-UTR using the following 
primers: 5′-GCT CGA GGA TGG GGA CTG AGA ACT GTG 
AGT CCT GGC GGGT-3′ and 5′-CTG AAG TGG GAA 
GGA CGA GG-3′. A fragment containing partial mCherry-
T2A-Cre was released from pENTR Maf B-P2A-FLAG-
mCherry-T2A-Cre-UTR using SbfI-HF and EcoRI-HF 
(New England Biolabs, Inc.). The second intermediate tar-
geting plasmid was linearized using CspCI and then was 
assembled with the amplified 3′-UTR fragment and the 
released mCherry-T2A-Cre fragment using Gibson Assem-
bly Master Mix (New England Biolabs, Inc.) to yield the 
final targeting plasmid.
The linearized final targeting plasmid was electropo-
rated into JM8.N4 mouse embryonic stem cells (C57BL/6N 
background; Knockout Mouse Project Repository). After se-
lection with G418 (EMD Millipore), targeted clones were 
individually picked, expanded, and screened by Southern 
blot analysis. First, homologous recombination was identi-
fied using BamHI-digested genomic DNA and a digoxigen-
in-labeled 3′-probe amplified using the following primers: 
5′-GGC ACC AGG GGA ATC TAG AA-3′ and 5′-ATG CTC 
CAA GAC AAC GAT GC-3′. Next, homologous recombina-
tion was confirmed using SwaI-digested genomic DNA and 
a digoxigenin-labeled 5′-probe amplified using the follow-
ing primers: 5′-CGC CTC CTA TGT GCC ATA AA-3′ and 
5′-TTT CTC CAA AGC AAG CCC TG-3′.
Targeted clones were injected into blastocysts, and male 
chimeras were bred to female C57BL/6NJ mice (stock no. 
000664; The Jackson Laboratory). Confirmation of ger-
mline transmission and determination of progeny geno-
type were performed by PCR using the following primers: 
5′-CGA GAA GAC GCA GCT CAT TC-3′ (common forward), 
5′-GAA TAG GGA GTC TGG GCC AG-3′ (wild-type re-
verse), and 5′-CTT GGT CAC CTT CAG CTT GG-3′ (mu-
tant reverse). The expected sizes of amplicons were 424 bp 
(mutant) and 219 bp (wild type).
cell preparation
Cheek pouch (submandibular) blood samples were collected 
using Microtainer tubes (BD) with EDTA after venipunc-
ture using a 4-mm Golden Rod Animal lancet (MEDIpoint) 
per the manufacturer’s instructions. Spleen samples were 
minced and digested in IMDM + 10% FCS (cIMDM) sup-
plemented with 250 µg/ml collagenase B (Roche) and 30 
U/ml DNase I (Sigma-Aldrich) for 30 min to 1 h at 37°C 
with stirring; LN samples were digested in the same man-
ner without mincing. Microglia were isolated from brain by 
density gradient centrifugation using Percoll (P4937; Sigma- 
Aldrich), modifying a previously described method (Lee and 
Tansey, 2013) by substituting IMDM for DMEM/Nutrient 
Mixture F-12 (DMEM/F-12) and by additionally supple-
menting the dissociation medium with 1.7 mg/ml collage-
nase D (Roche), also omitting papain. In brief, brains were 
diced, dissociated in medium supplemented with Liberase 
TM (Roche), washed, filtered, and suspended in 37% Per-
coll. 70% Percoll was underlaid and 30% Percoll was overlaid. 
HBSS (Thermo Fisher Scientific) was overlaid, and samples 
were centrifuged before cells in the interface between 37% 
Percoll and 70% Percoll were recovered and washed. Perito-
neum samples were harvested by injecting 10 ml PBS into 
the peritoneal cavity, agitating vigorously, and then collect-
ing the injected fluid. BM samples were obtained by flushing 
the femur (or both the femur and the tibia) with magnetic- 
activated cell-sorting (MACS) buffer (PBS + 0.5% BSA + 
2 mM EDTA). Epidermis samples were prepared by splitting 
ears into dorsal and ventral halves, incubating atop RPMI-
1640 medium + 1.25 U/ml dispase (Roche) for 45 min to 
1 h at 37°C, peeling and mincing epidermal sheets, and di-
gesting in 0.05% trypsin-EDTA solution (Gibco) for 40 min 
at 37°C followed by repetitive pipetting. Lung samples were 
prepared after perfusion by injection of 5–10 ml PBS into 
the right ventricle; lung lobes were minced and digested in 
cIMDM supplemented with 2–4 mg/ml collagenase D and 
30 U/ml DNase I for 1–2 h at 37°C with stirring. Small in-
testinal lamina propria samples were prepared as follows: after 
removal of Peyer’s patches and fat, intestines were opened 
longitudinally, washed of fecal content, cut into pieces 1 cm 
in length, and incubated in HBSS + 15 mM Hepes + 5 mM 
EDTA at 37°C for 40 min with shaking at 250 rpm. Tissue 
suspensions were passed through a sieve, and the tissue pieces 
remaining were washed twice in PBS, minced, and incubated 
in cIMDM supplemented with collagenase B, collagenase D, 
and DNase I for 90 min at 37°C with stirring. Cell suspen-
sions were pelleted, suspended in 40% Percoll, overlaid on 
70% Percoll, and centrifuged for 20 min at 850 g before cells 
in the interface were recovered and washed in PBS.
To remove erythrocytes, samples were treated with 
ACK lysing buffer (0.15 M NH4Cl + 10 mM KHCO3 + 
0.10  mM EDTA). Cells were filtered through 36-µm or 
80-µm nylon mesh before resuspension in MACS buffer, 
and any cell counts were determined using a Vi-CELL ana-
lyzer (Beckman Coulter).
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Antibodies and flow cytometry
Samples were stained in MACS buffer at 4°C in the presence 
of Fc Block (2.4G2; BD). The following antibodies purchased 
from BD, BioLegend, eBioscience, or Tonbo Biosciences were 
used to detect surface markers by flow cytometry: anti-CD3e 
(145-2C11) conjugated to biotin or FITC; anti-CD11b 
(M1/70) conjugated to eFluor 450, Pacific blue, FITC, PE, 
PE-Cy7, Alexa Fluor (AF) 700, or APC-Cy7; anti-CD11c 
(N418) conjugated to biotin, PerCP-Cy5.5, AF 647, or 
APC-Cy7; anti-CD11c (HL3) conjugated to Brilliant Vio-
let 395; anti-CD19 (1D3) conjugated to biotin; anti-CD24 
(M1/69) conjugated to PE, PE-Cy7, or AF 647; anti-CD43 
(S7) conjugated to APC; anti-CD45 (30-F11) conjugated to 
eVolve 605; anti-CD45.2 (104) conjugated to Brilliant vio-
let (BV) 605, PerCP-Cy5.5, APC, APC-Cy7, or APC–eFluor 
780; anti-CD45R (B220; RA3-6B2) conjugated to eFluor 
450, BV 510, PE-Cy7, AF 700, or APC-Cy7; anti-CD62L 
(MEL-14) conjugated to APC; anti-CD64 (X54-5/7.1) con-
jugated to AF 647 or APC; anti-CD102 (3C4 [MIC2/4]) 
conjugated to AF 647; anti-CD103 (M290) conjugated to BV 
421; anti-CD115 (M-CSFR; AFS98) conjugated to BV 711, 
PerCP-eFluor 710, or PE; anti-CD117 (Kit; 2B8) conjugated 
to APC–eFluor 780; anti-CD135 (Flt3; A2F10) conjugated 
to APC; anti-CD170 (Siglec-F; E50-2440) conjugated to PE; 
anti-CD172a (Sirp-α; P84) conjugated to PerCP–eFluor 710, 
PE-Cy7, or APC; anti-CD207 (langerin; eBioL31) conjugated 
to biotin or PE; anti-CD226 (10E5) conjugated to PE; an-
ti-CD326 (EpCAM; G8.8) conjugated to APC; anti-FcεRIα 
(MAR-1) conjugated to biotin; anti–Ly-6C (AL-21) conju-
gated to AF 700 or APC; anti–Ly-6C (HK1.4) conjugated to 
APC–eFluor 780; anti–Ly-6G (1A8) conjugated to biotin, BV 
510, PerCP-Cy5.5, or PE; anti-NK1.1 (PK136) conjugated 
to eFluor 450; anti-F4/80 (BM8) conjugated to PE-Cy7 or 
APC–eFluor 780; anti–TER-119 conjugated to eFluor 450; 
and anti–MHC-II (I-A/I-E; M5/114.15.2) conjugated to BV 
421, Pacific blue, V500, or BV 510. Streptavidin conjugated to 
eFluor 450 (eBioscience) or to BV 510 (BD) was also used for 
flow cytometry. To detect intracellular protein, samples were 
fixed, permeabilized, and washed using a Transcription Factor 
Buffer set (BD). The following antibody from BD was used 
after fixation and permeabilization: anti-Zbtb46 (U4-1374) 
conjugated to PE. Cells were analyzed using a FAC SCanto 
II or FAC SAria Fusion flow cytometer (BD), and data were 
analyzed using FlowJo software (Tree Star). All gating strate-
gies incorporated size and doublet discrimination based on 
forward and side scatter parameters.
Gene expression microarray analysis
RNA was isolated from cells using an RNAqueous-Micro 
kit (Ambion), and target preparation was performed using 
the GeneChip WT Pico kit (Affymetrix) for hybridization to 
Mouse Gene 1.0 ST arrays (Affymetrix). Data were normalized, 
and expression values were modeled using ArrayStar 5 software 
(DNA STAR). Original microarray data have been deposited 
in Gene Expression Omnibus under accession no. GSE86596.
For principal component analysis, data were preprocessed 
using ArrayStar 5 software with robust multiarray average 
summarization and quantile normalization. Replicates were 
grouped by sample, and then, mean log-transformed expression 
values from each replicate group were exported in table format, 
imported into R software (R Foundation for Statistical Com-
puting), mean-centered by gene, root-mean-square–scaled by 
sample, transposed, and subjected to principal component anal-
ysis computed by singular value decomposition without addi-
tional centering or scaling. Scores were plotted in R software.
Microscopy
Peritoneal macrophages and DCs were sorted using a FAC 
SAria Fusion flow cytometer (BD), concentrated by Cyto-
spin, and stained with Wright–Giemsa stain using the Hema 3 
system (Thermo Fisher Scientific). Bright-field images were 
captured at room temperature with a 40× objective lens using 
an EVOS FL Auto Imaging system (Invitrogen).
rt-Pcr
For each biological replicate, peritoneum samples were iso-
lated either from mice homozygous for the neomycin resis-
tance cassette–deleted Maf B-mCherry-Cre allele (Maf bcre/
cre) or from wild-type control mice. Between 1 × 105 and 
2 × 105 LPMs were sorted from each sample using a FAC 
SAria Fusion flow cytometer (BD), RNA was isolated using 
an RNAqueous-Micro kit (Ambion) according to the man-
ufacturer’s instructions, first-strand cDNA was synthesized 
using qScript cDNA SuperMix (Quantabio), and quantita-
tive analysis was performed using the LightCycler 480 sys-
tem (Roche) with Luminaris Color HiGreen qPCR Master 
Mix (Thermo Fisher Scientific) and the following primer 
pairs: Maf b coding sequence (Sato-Nishiwaki et al., 2013), 
5′-CGT CCA GCA GAA ACA TCA CC-3′ and 5′-TCG CAC 
TTG ACC TTG TAG GC-3′; and Hprt1 (PrimerBank ID 
7305155a1), 5′-TCA GTC AAC GGG GGA CAT AAA-3′ and 
5′-GGG GCT GTA CTG CTT AAC CAG-3′.
LPs
Mice were injected intravenously with 7.5 µg anti-CD209a (DC-
SIGN; MMD3) antibody conjugated to eF660 (eBioscience) with 
or without 5 µg LPS (from Escherichia coli O55:B5; Sigma-Al-
drich) diluted in 0.9% sodium chloride to a final volume of 200 µl, 
and then, inguinal LN samples were prepared 12 h after treatment.
hdM antigen
HDM antigen (Dermatophagoides pteronyssinus extracts; 
Greer Laboratories) was dissolved in PBS. Mice were sensitized 
and challenged intratracheally, as outlined in Fig. 5 (A or C), 
to induce allergic airway inflammation, and lung and medias-
tinal LN samples were prepared 2 or 3 d after final challenge.
online supplemental material
Fig. S1 and S2 show flow cytometry gating strategies used to 
identify cell populations analyzed in this study. Tables S1 and 
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S2 detail primers used in the generation of the Maf B-mCher-
ry-Cre targeting plasmid.
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Figure S1. Gating strategies for the identification of monocytes, macrophages, and other populations by flow cytometry. (A–H) After size and 
doublet discrimination using forward scatter (FSC) and side scatter (SSC) properties, samples isolated from the spleen (A), brain (B), blood (C), lamina propria 
(D), BM (E), lung (F), peritoneum (G), or inguinal LN (H) were gated as indicated before further analysis in Fig. 2 and 3. Shown are representative two-color 
histograms; numbers indicate percentage of cells within the indicated gate. mo., monocytes; MΦ, macrophages.
Mafb lineage tracing marks macrophages | Wu et al.s16
Figure S2. Gating strategies for the identification of Lcs in the epidermis and monocyte-derived cells in the inflamed lung by flow cytome-
try. (A–C) After size and doublet discrimination using forward scatter and side scatter properties, samples isolated from the epidermis (A and B) or lung 
(C) were gated as indicated before further analysis in Fig. 4 and 5. Shown are representative two-color histograms; numbers indicate percentage of cells 
within the indicated gate.
s17JEM
Table S1. Primers for the amplification of coding sequences by Pcr
Product Primer sequence (5′→3′)
P2A-FLAG-mCherry coding 
sequence
ATT ACT CGA GGG CAG CGG CGC CAC GAA CTT CAG CCT GCT GAA GCA AGC AGG AGA TGT TGA AGA AAA CCC CGG CCC TGA TTA CAA GGA TGA CGA 
TGA CAA GGT GAG CAA GGG CGA GGAG
ATT ATC CGG ATC CTC TAG ACT TGT ACA GCT CGT CCA TGC
T2A-Cre coding sequence ATT ATC TAG AGG ATC CGG AGA GGG CAG AGG AAG TCT TCT AAC ATG CGG TGA CGT GGA GGA GAA TCC CGG CCC TGT GCC CAA GAA GAA GAG GAA
ATT AGA ATT CTC AGT CCC CAT CCT CGA GCAG
MafB coding sequence ATT AAG ATC TCA CCA TGG CCG CGG AGC TGA GCAT
ATT AGT CGA CCA GAA AGA ACT CAG GAG AGG AG
Table S2. Primers for the amplification of homology arms and vector backbone by Pcr
Product Primer sequence (5′→3′)
5′–homology arm                               CCA TGA TTA CGC CAA GCT ATC GGA GTG TGG TGT TCT CTCT
                              TGA CCT TGT AGG CGT CTC TC
3′–homology arm                               CAT ACA CAC ACC CAC GAC TG
                              AAC GAC GGC CAG TGA ATT ATC GGG ACA AAC AAA GAT GTTC
Vector backbone                               CCA CAC TCC GAT AGC TTG GCG TAA TCA TGG
                              GTT TGT CCC GAT AAT TCA CTG GCC GTC GTT
